|
Authored by: Anonymous on Thursday, August 02 2012 @ 08:34 AM EDT |
Are you referring to companies patenting genes or other patent-related issues
with pharmaceutical companies? I'm just curious.
Regards,
mc (Crud! I forgot to log in!)[ Reply to This | Parent | # ]
|
|
Authored by: Anonymous on Thursday, August 02 2012 @ 03:26 PM EDT |
Where the patent was on a process of:
take a blood
reading
measure component X
increase/decrease based on
measurement
You can implement that process in software. Not the full
process, but the comparison and decision to increase/decrease drug dosage.
Therefore, it's possible it would fall under the description of a "software
patent"1 and thereby be eligible for costs.
:)
1:
Depending on how it's argued and what the Judges would view as the active part
of the patent relative to the new description.
RAS[ Reply to This | Parent | # ]
|
|
|
|
|